← BackPRO DEX INC · Surgical & Medical Instruments & ApparatusPDEX
Low riskNext report: In 1 days (est.)
The short versionA profitable company with growing sales.
Going well
- Sales up 17% in the latest quarter vs a year ago
- Profitable every year for 10 years
- Sales up 24% last year
Money moves
- No insider buying or selling in the last 30 days
- Institutions cut 1.9% from their holdings in the quarter ending June 2026 (39 bought, 26 sold)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$60.75-2.5% that day
- Company value
- $195M
- Share price times all shares
- Price vs profit (P/E)
- 14.8x
- You pay about $15 for each $1 of yearly profit
- Price vs sales
- 2.5x
- Company value is 2.5 times a year of sales
- Cash vs value
- 4%
- Cash as a share of company value
- Debt vs value
- 8%
- Debt as a share of company value
From PDEX's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26 (worked out from yearly totals)$20.4M+17% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $77.5M, up 16% from the 12 months before. Over 5 years, sales grew about 14% a year.
Business quality
The checklist Warren Buffett-style investors use. Annual numbers for 2025.- PassReturn on equity 15%+Earns a lot on the money owners have in the business.24.5%
- PassDebt under half of equityNot relying on borrowed money.0.37x equity
- PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.13.5%
- PassProfitable every yearSteady profits, not one good year.10 of 10 years
- MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$2.9M
- PassShare count not growingNot diluting owners. Falling means buybacks.-10.7% in 3 years
- MissGross margin 40%+Pricing power: sells for well above what it costs to make.29.3%
- Revenue
- $66.6M
- +23.7% vs prior year
- 5-year growth
- +13.8%/yr
- revenue, per year
- Total debt
- $15.4M
- 0.37x equity
- Current ratio
- 4.03x
- short-term assets / bills due
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jun 30, 2026- Revenue
- $20.4M
- +16.6% YoY
- EPS
- $0.85
- vs $0.36
- Op. margin
- 17.3%
- +9.6 pts
- Gross margin
- 34.8%
- +14.8 pts
- Free cash flow
- -$476K
- Share count
- -1.8%
- vs a year ago
Some values are worked out from year-to-date totals in the annual report.
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trendNo trades to chart yet.
Filing buzz
Last 7 days vs normal
0/ 100
- This week
- 0
- Normal week
- 1.0
- vs normal
- 0.0x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
■Steady-1.9%Institutions cut 1.9% from their holdings. 39 bought, 26 sold.
Shares held by institutions734K
Sep '24Jun '26
Share count growthYearly rate, last 3 years
-3.4%Cash runwayAt last year's cash burn
Cash flow positiveDebt to equityLatest balance sheet: debt compared with what owners have
0.4x · $17.5M debtShares outstandingLatest reported
3MNext reportIn 1 days (est.)Estimated from the same quarter last year
- Results filedSep 3
- Results filedApr 30
- Results filedJan 29
- Results filedOct 30, 2025
- Results filedSep 4, 2025
Flags and big holders
Offerings 6 months, flags 12 months, holders 90 days
No offerings, red flags or new big holders. Clean record.
Insider trades
Open-market buys and sells, last 90 days
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
Latest filings
Straight from SEC EDGAR
SoldKirk Richard Lee Jr VanChief Executive Officer, Director
765 shares at $59.36 avg ($58.94 to $59.62) · $45K
- -1% of holdings
- Now owns 79,228 shares
- Pre-planned sale (10b5-1)
- 2 transactions
- Filed 3 days after trade
SoldAlisha CharltonChief Financial Officer
2,300 shares at $61.30 avg ($61.05 to $61.76) · $141K
- -10% of holdings
- Now owns 21,870 shares
- Not a pre-planned sale
- 2 transactions
- Filed 1 day after trade
SoldKirk Richard Lee Jr VanChief Executive Officer, Director
19,235 shares at $60.58 avg ($58.66 to $64.70) · $1.2M
- -19% of holdings
- Now owns 79,993 shares
- Pre-planned sale (10b5-1)
- 9 transactions
- Filed 1 day after trade
Stock awardAngelita Rebamontan DomingoDirector
19 shares at $33.25 · $632
- +0% of holdings
- Now owns 18,798 shares
- Filed 1 day after trade
SoldAngelita Rebamontan DomingoDirector
998 shares at $47.24 · $47K
- -5% of holdings
- Now owns 18,779 shares
- Not a pre-planned sale
- Filed 120 days after trade
Stock awardKirk Richard Lee Jr VanChief Executive Officer, Director
14,800 shares
- +16% of holdings
- Now owns 104,507 shares
- Filed 5 days after trade
- Also: Shares withheld for taxes